“

In some patients, it looks like people who had the disease but now recovered have kind ofthese sort of low antibodies levels, but we dont know if thats a consistent result across everybody thats contracted the virus so far, so, we need to learn more about how the virus affects people and how people are affected by that infection before we can see too much about how that impacts vaccine design.